Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. [electronic resource]
Producer: 20071130Description: 991-8 p. digitalISSN:- 0270-9139
- Adult
- Antidepressive Agents -- therapeutic use
- Antiviral Agents -- adverse effects
- Depression -- chemically induced
- Drug Therapy, Combination
- Female
- Genotype
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- adverse effects
- Logistic Models
- Male
- Mental Disorders -- complications
- Middle Aged
- Polyethylene Glycols -- adverse effects
- Prospective Studies
- Recombinant Proteins
- Ribavirin -- adverse effects
- Risk Factors
- Substance-Related Disorders -- complications
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.